Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

Volumn 19, Issue 3, 2008, Pages 595-597

  Cottu, P H ^a   Asselah, J ^a   Lae, M ^a   Pierga, J Y ^a   Dieras V ^a   Mignot, L ^a   Sigal Zafrani, B ^a   Vincent Salomon, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; DEOXYCYTIDINE; DOCETAXEL; DRUG DERIVATIVE; FLUOROURACIL; MONOCLONAL ANTIBODY; TAXOID; TRASTUZUMAB;

BREAST TUMOR; CASE REPORT; FEMALE; GENETICS; HUMAN; LETTER; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PROTO ONCOGENE; REMISSION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; GENES, ERBB-2; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; REMISSION INDUCTION; TAXOIDS;

EID: 40549092394     PISSN: None     EISSN: 15698041     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)